D Lennon

Summary

Affiliation: University of Auckland
Country: New Zealand

Publications

  1. pmc Invasive group A streptococcal infection and vaccine implications, Auckland, New Zealand
    Atheer Safar
    Auckland City Hospital, Auckland, New Zealand
    Emerg Infect Dis 17:983-9. 2011
  2. ncbi request reprint Nurse-led school-based clinics for skin infections and rheumatic fever prevention: results from a pilot study in South Auckland
    Sarah Gray
    Counties Manukau District Health Board, Auckland, New Zealand
    N Z Med J 126:53-61. 2013
  3. ncbi request reprint The epidemiology of rheumatic fever in the Tairawhiti/Gisborne region of New Zealand: 1997-2009
    Victoria Siriett
    The University of Auckland, Auckland, Tamaki Campus, School of Population Health, Auckland, 1142, New Zealand
    N Z Med J 125:8-15. 2012
  4. doi request reprint Reducing inequalities with vaccines: New Zealand's MeNZB vaccine initiative to control an epidemic
    Diana Lennon
    Community Paediatrics, The University of Auckland, Auckland, New Zealand
    J Paediatr Child Health 48:193-201. 2012
  5. doi request reprint Once-daily amoxicillin versus twice-daily penicillin V in group A beta-haemolytic streptococcal pharyngitis
    D R Lennon
    Department of Paediatrics, University of Auckland, Private Bag 92019, Auckland, New Zealand
    Arch Dis Child 93:474-8. 2008
  6. ncbi request reprint Meta-analysis of trials of streptococcal throat treatment programs to prevent rheumatic fever
    Diana Lennon
    Community Paediatrics, University of Auckland, Auckland, New Zealand
    Pediatr Infect Dis J 28:e259-64. 2009
  7. doi request reprint Fast tracking the vaccine licensure process to control an epidemic of serogroup B meningococcal disease in New Zealand
    Diana Lennon
    Community Paediatrics, School of Population Health, University of Auckland, Private Bag 92019, Auckland, New Zealand
    Clin Infect Dis 49:597-605. 2009
  8. doi request reprint School-based prevention of acute rheumatic fever: a group randomized trial in New Zealand
    Diana Lennon
    Department of Paediatrics, University of Auckland, Auckland, New Zealand
    Pediatr Infect Dis J 28:787-94. 2009
  9. ncbi request reprint Acute rheumatic fever in children: recognition and treatment
    Diana Lennon
    Department of Paediatrics, University of Auckland, Auckland, New Zealand
    Paediatr Drugs 6:363-73. 2004
  10. ncbi request reprint Guidelines for sore throat management in New Zealand
    Melissa Kerdemelidis
    Community Paediatrics, School of Population Health, The University of Auckland, Auckland, New Zealand
    N Z Med J 122:10-8. 2009

Collaborators

Detail Information

Publications31

  1. pmc Invasive group A streptococcal infection and vaccine implications, Auckland, New Zealand
    Atheer Safar
    Auckland City Hospital, Auckland, New Zealand
    Emerg Infect Dis 17:983-9. 2011
    ..Seventy-four percent of patients who died had an underlying condition. To the population in our study, the proposed 26-valent vaccine would provide limited benefit...
  2. ncbi request reprint Nurse-led school-based clinics for skin infections and rheumatic fever prevention: results from a pilot study in South Auckland
    Sarah Gray
    Counties Manukau District Health Board, Auckland, New Zealand
    N Z Med J 126:53-61. 2013
    ..To assess the acceptability and feasibility of delivering targeted primary health care in a decile one primary school setting...
  3. ncbi request reprint The epidemiology of rheumatic fever in the Tairawhiti/Gisborne region of New Zealand: 1997-2009
    Victoria Siriett
    The University of Auckland, Auckland, Tamaki Campus, School of Population Health, Auckland, 1142, New Zealand
    N Z Med J 125:8-15. 2012
    ..To establish Acute Rheumatic Fever (ARF) rates within the Tairawhiti District Health Board (1997-2009) to identify communities for primary prevention programmes...
  4. doi request reprint Reducing inequalities with vaccines: New Zealand's MeNZB vaccine initiative to control an epidemic
    Diana Lennon
    Community Paediatrics, The University of Auckland, Auckland, New Zealand
    J Paediatr Child Health 48:193-201. 2012
    ....
  5. doi request reprint Once-daily amoxicillin versus twice-daily penicillin V in group A beta-haemolytic streptococcal pharyngitis
    D R Lennon
    Department of Paediatrics, University of Auckland, Private Bag 92019, Auckland, New Zealand
    Arch Dis Child 93:474-8. 2008
    ..Rheumatic fever is a preventable chronic disease preceded by group A beta-haemolytic streptococcal (GABHS) pharyngitis...
  6. ncbi request reprint Meta-analysis of trials of streptococcal throat treatment programs to prevent rheumatic fever
    Diana Lennon
    Community Paediatrics, University of Auckland, Auckland, New Zealand
    Pediatr Infect Dis J 28:e259-64. 2009
    ..Rheumatic fever (RF) is the commonest cause of pediatric heart disease globally. Penicillin for streptococcal pharyngitis prevents RF. Inequitable access to health care persists...
  7. doi request reprint Fast tracking the vaccine licensure process to control an epidemic of serogroup B meningococcal disease in New Zealand
    Diana Lennon
    Community Paediatrics, School of Population Health, University of Auckland, Private Bag 92019, Auckland, New Zealand
    Clin Infect Dis 49:597-605. 2009
    ....
  8. doi request reprint School-based prevention of acute rheumatic fever: a group randomized trial in New Zealand
    Diana Lennon
    Department of Paediatrics, University of Auckland, Auckland, New Zealand
    Pediatr Infect Dis J 28:787-94. 2009
    ..The efficacy of injectable penicillin, in high rheumatic fever incidence military environments is indisputable...
  9. ncbi request reprint Acute rheumatic fever in children: recognition and treatment
    Diana Lennon
    Department of Paediatrics, University of Auckland, Auckland, New Zealand
    Paediatr Drugs 6:363-73. 2004
    ..Primary prevention has been achieved innovatively in some countries, for example, Costa Rica, and more conventionally in some developed countries. Treatment of the acute episode controls symptoms and may limit cardiac damage...
  10. ncbi request reprint Guidelines for sore throat management in New Zealand
    Melissa Kerdemelidis
    Community Paediatrics, School of Population Health, The University of Auckland, Auckland, New Zealand
    N Z Med J 122:10-8. 2009
    ..An algorithm and guideline for appropriate screening and management of sore throats in the New Zealand setting was crafted to guide appropriate treatment in high risk rheumatic fever areas and reduce antibiotic use in low risk areas...
  11. pmc Immunogenicity, reactogenicity, and safety of a P1.7b,4 strain-specific serogroup B meningococcal vaccine given to preteens
    Jamie Hosking
    University of Auckland, Private Bag 92019, Auckland, New Zealand
    Clin Vaccine Immunol 14:1393-9. 2007
    ....
  12. ncbi request reprint Communicating information about sore throats and rheumatic fever to South Auckland high-school students
    N Harre
    Department of Psychology, University of Auckland
    N Z Med J 113:215-7. 2000
    ..The present study examined the effectiveness of three modes of communication designed to increase high school students' knowledge about throat infections and rheumatic fever in a high risk area...
  13. pmc Delayed immunisation and risk of pertussis in infants: unmatched case-control study
    Cameron C Grant
    Department of Paediatrics, Faculty of Medicine and Health Sciences, University of Auckland, Private Bag 92019, Auckland, New Zealand
    BMJ 326:852-3. 2003
  14. ncbi request reprint Proceedings of the Meningococcal Vaccine Strategy World Health Organization satellite meeting, 10 March 2004, Auckland, New Zealand
    Kerry Sexton
    University of Auckland, Auckland
    N Z Med J 117:1 p preceding U1027. 2004
    ..This will include real-time hospital-based monitoring in the regions first to roll out the vaccine...
  15. ncbi request reprint New zealand epidemic strain meningococcal B outer membrane vesicle vaccine in children aged 16-24 months
    Sharon Wong
    The University of Auckland, Auckland, New Zealand
    Pediatr Infect Dis J 26:345-50. 2007
    ..7b,4 since 1991. Children younger than 5 years are at highest risk. Previous serogroup B outer membrane vesicle (OMV) strain specific vaccines have shown variable efficacy in this age group...
  16. ncbi request reprint Safety and immunogenicity of New Zealand strain meningococcal serogroup B OMV vaccine in healthy adults: beginning of epidemic control
    V Thornton
    The University of Auckland, Meningococcal B Project, P O Box 98847, South Auckland Mail Centre, Auckland, New Zealand
    Vaccine 24:1395-400. 2006
    ..The safety and immunogenicity profile observed in this study of healthy adults enabled studies in children to be initiated using 25 microg dosage...
  17. pmc Incidence, risk factors, and outcomes of Panton-Valentine leukocidin-positive methicillin-susceptible Staphylococcus aureus infections in Auckland, New Zealand
    S Muttaiyah
    Department of Microbiology, Auckland City Hospital, Grafton, Auckland, New Zealand
    J Clin Microbiol 48:3470-4. 2010
    ..Those patients with PVL-positive MSSA infection were more likely to be of Pacific ethnicity, be younger in age, have community-onset infection, have SSTI, and need surgical intervention...
  18. doi request reprint Antibody persistence following MeNZB vaccination of adults and children and response to a fourth dose in toddlers
    Catherine Jackson
    Epidemiology and Biostatistics, Community Paediatrics, School of Population Health Tamaki Campus, University of Auckland, Auckland, New Zealand
    Arch Dis Child 96:744-51. 2011
    ..A New Zealand serogroup B meningococcal epidemic prompted trials of a strain-specific (B:4:P1.7-2,4) outer membrane vesicle vaccine (MeNZB)...
  19. ncbi request reprint An Auckland regional audit of the nurse-led rheumatic fever secondary prophylaxis programme
    Sarah Grayson
    Starship Hospital, Auckland District Health Board
    N Z Med J 119:U2255. 2006
    ..Rheumatic fever with ensuing rheumatic heart disease is considered to be a preventable chronic disease...
  20. ncbi request reprint Monoarthritis in rheumatic fever?
    Elizabeth Wilson
    Pediatr Infect Dis J 26:369-70. 2007
  21. ncbi request reprint The New Zealand Meningococcal Vaccine Strategy: a tailor-made vaccine to combat a devastating epidemic
    Kerry Sexton
    Meningococcal Vaccine Strategy, Ministry of Health, Wellington, New Zealand
    N Z Med J 117:U1015. 2004
    ..A summary of the efficacy and safety data of existing outer membrane vesicle group B meningococcal vaccines is included as these data critically support the Strategy...
  22. ncbi request reprint Vaccine preventable diseases in indigenous populations - International perspectives. Satellite Symposium of the 5th International Symposium on Pneumococci and Pneumococcal Diseases, April 2006, Alice Springs, Australia
    Rob Menzies
    National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, The Children s Hospital at Westmead, Locked Bag 4001, Westmead, New South Wales 2145, Australia
    Vaccine 25:7281-4. 2007
  23. ncbi request reprint The strategy to control New Zealand's epidemic of group B meningococcal disease
    Jane O'Hallahan
    New Zealand Ministry of Health, Wellington, New Zealand
    Pediatr Infect Dis J 23:S293-8. 2004
    ..In New Zealand today, babies of Pacific ethnicity born in South Auckland have a 1-in-48 chance of contracting meningococcal disease by the time they are 5 years of age...
  24. ncbi request reprint MeNZB: a safe and highly immunogenic tailor-made vaccine against the New Zealand Neisseria meningitidis serogroup B disease epidemic strain
    Philipp Oster
    Chiron Vaccines, Siena, Italy
    Vaccine 23:2191-6. 2005
    ..In conclusion, these findings suggest that MeNZB is safe and is likely to confer protection against systemic group B meningococcal disease caused by the epidemic strain...
  25. ncbi request reprint From secondary prevention to primary prevention: a unique strategy that gives hope to a country ravaged by meningococcal disease
    Jane O'Hallahan
    Ministry of Health, Level 1, Old Bank Chambers, Customhouse Quay, P O Box 5013, Wellington, New Zealand
    Vaccine 23:2197-201. 2005
    ..Planning, co-ordinating and delivering the immunisation programme is a challenging project for the New Zealand Health Sector...
  26. ncbi request reprint Re: Immunogenicity and safety of a strain-specific MenB OMV vaccine delivered to under 5 year olds in New Zealand, Oster P, O'Hallahan J, Aaberge I, Tilman S, Ypma E, Martin D. Vaccine 2007;25(16):3075-9
    Diana Lennon
    Vaccine 25:6835; author reply 6835-6. 2007
  27. ncbi request reprint Rheumatic fever diagnosis, management, and secondary prevention: a New Zealand guideline
    Polly Atatoa-Carr
    Waikato District Health Board, Hamilton
    N Z Med J 121:59-69. 2008
    ..This paper is a brief summary...
  28. doi request reprint The diagnosis and management of chronic rheumatic heart disease--an Australian guideline
    Warren Walsh
    Department of Cardiovascular Medicine, The Prince of Wales Hospital, Sydney, Australia
    Heart Lung Circ 17:271-89. 2008
  29. ncbi request reprint The role of MeNZB vaccination in controlling the New Zealand meningococcal epidemic
    Diana Lennon
    N Z Med J 121:110-2. 2008
  30. doi request reprint Re: "a prospective study of the effectiveness of the New Zealand meningococcal B vaccine"
    Diana Lennon
    Am J Epidemiol 167:1140-1; author reply 1141-2. 2008
  31. ncbi request reprint Persistence of oral polio vaccine virus after its removal from the immunisation schedule in New Zealand
    Q Sue Huang
    Institute of Environmental Science and Research, PO Box 50348, Porirua, New Zealand
    Lancet 366:394-6. 2005
    ..Sequence homology with Sabin vaccine parent strains indicated that polioviruses detected more than 4 months after the switch were of recent origin, consistent with importation from OPV-using countries...